Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 139Esophageal Neoplasms 125Pancreatic Neoplasms 96Esophageal Squamous Cell Carcinoma 84Colorectal Neoplasms 66Adenocarcinoma Of Esophagus 53Stomach Neoplasms 40Carcinoma, Hepatocellular 40Colonic Neoplasms 19Anus Neoplasms 18Neoplasms 14Liver Neoplasms 12Cholangiocarcinoma 10Adenocarcinoma 8Carcinoma, Squamous Cell 7Bile Duct Neoplasms 7Anal Canal Carcinoma 7Head and Neck Neoplasms 6Breast Neoplasms 6Brain Neoplasms 6Prostatic Neoplasms 5Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Sarcoma 4Vulvar Neoplasms 3

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Neoadjuvant Therapy 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer × Radiotherapy × Gastrointestinal × Clear all
NCT03503630 2024-01-31

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

American University of Beirut Medical Center

Phase 2 Unknown
44 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT03770689 2023-03-21

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

EMD Serono

Phase 1/2 Completed
19 enrolled 21 charts
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡